참고문헌
- Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997; 89 (17):1260-270 https://doi.org/10.1093/jnci/89.17.1260
- Kurahara S, Shinohara M, Ikebe T, et al: Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 1999;21 (7):627-638 https://doi.org/10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.0.CO;2-2
- Imanishi Y, Fujii M, Tokumaru Y, et al: Clinical significance of expression of membrane type I matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol. 2000;31 (8):895-904 https://doi.org/10.1053/hupa.2000.9756
- Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993;9:541-573 https://doi.org/10.1146/annurev.cb.09.110193.002545
- Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer. 1996;69 (1):9-16 https://doi.org/10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8
- Maeta H, Ohgi S, Terada T: Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch. 2001:438 (2):121-128 https://doi.org/10.1007/s004280000286
- Korem S, Kraiem Z, Shiloni E, Yehezkel O, Sadeh O, Resnick MB: Increased expression of matrix metalloproteinase-2: a diagnostic marker but not prognostic marker of papillary thyroid carcinoma. Isr Med Assoc J. 2002;4 (4):247-251
- Baldini E, Toller M, Graziano PM, Russo FP, Pepe M, Biordi L, et al: Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid. 2004;14 (11):881-888 https://doi.org/10.1089/thy.2004.14.881
- Nakamura H, Ueno H, Yamashita K, et al: Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res. 1999;59 (2):467-473
- Pelizzo MR, Boschin IM, Toniato A, et al: Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun. 2004;25 (6):547-552 https://doi.org/10.1097/01.mnm.0000126625.17166.36
- Matrisian LM: The matrix-degrading metalloproteinases. Bioessays. 1992;14 (7):455-463 https://doi.org/10.1002/bies.950140705
- Azzam HS, Arand G, Lippman ME, Thompson EW: Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst. 1993;85 (21):1758-1764 https://doi.org/10.1093/jnci/85.21.1758
- Kameyama K: Expression of MMP-1 in the capsule of thyroid cancer-relationship with invasiveness. Pathol Res Pract. 1996; 192 (1):20-26 https://doi.org/10.1016/S0344-0338(96)80125-7
- Zedenius J, Stahle-Backdahl M, Enberg U, Grimelius L, Larsson C, Wallin G, et al: Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA. World J Surg. 1996;20 (1):101-106 https://doi.org/10.1007/s002689900018
- Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W: Distribution of the 72-kd type N collagenase in nonneo-plastic and neoplastic thyroid tissue. Hum Pathol. 1992;23 (12): 1395-1401 https://doi.org/10.1016/0046-8177(92)90060-G
- Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst. 1991;83 (11):775-779 https://doi.org/10.1093/jnci/83.11.775
- Imren S, Kohn DB, Shimada H, Blavier L, DeClerck YA: Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 1996;56 (13):2891-2895
- Yu AE, Hewitt RE, Kleiner DE, Stetler-Stevenson WG: Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2. Biochem Cell Biol. 1996;74 (6):823-831 https://doi.org/10.1139/o96-088
- Grignon DJ, Sakr W, Toth M, et al: High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res. 1996; 56 (7):1654-1659
- Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92 (8):827-839 https://doi.org/10.1161/01.RES.0000070112.80711.3D